Discovery on Target 2019 Quotes
The scientific sessions, attendees to exhibition and networking at Discovery on Target were of fantastic quality. The conference is not massively huge that it becomes too impersonal; one can still learn the latest research and exchange ideas with both industry and academic leaders at a one-on-one level. A must go for those working with membrane targets.
The “casual” way of saying this is that I felt that I was swimming in a pool full of high quality fish (prospects). Every corner that I was turning, there was somebody interested in the technology we offer so we walked out with many good leads.
-- Vice President, Marketing & Business Development, Biosensing Instrument
While Key Organics Inc. is always represented at Discovery on Target - this was my first time – and I was pleasantly surprised at the quality of connections I was able to make. It was a well-run conference with ample opportunity to have many thoughtful
conversations with scientists interested in our areas of expertise.
-- U.S. Operations Manager, Key Organics Inc.
The Ubiquitin ligase and PROTAC conferences were well run and featured nearly all major players in the field. The talks were informative, and the schedule allowed for lively discussions between researchers across academia and industry and often provided
valuable insights. There were several key takeaways that I hope to apply at my own institution.
As always it was an inspiring and informative conference. Not a bad speaker in sight.
-- CSO, AdAlta
I wanted to thank you for organizing such a wonderful meeting with top leaders and great topics in different forums. I made a lot of new friends and learned a lot. I would love to participate in the future and will be in touch.
-- Senior Research Investigator, Bristol-Myers Squibb
The conference was an excellent assembly of academic and industrial leaders in the field of targeted protein degradation. Representatives from nearly every major player in the area were either presenting data or were in attendance. The “medium size”
of the conference and ample opportunities for social interactions enabled numerous useful person-to-person conversations that augmented the highly informative scientific presentations. I left the meeting with many new perspectives of the field as
well as with fresh ideas and directions for my own targeted protein degradation research.
-- Principal Scientist, Genentech
It was an excellent meeting and I think it will lead to two new collaborations for me.
-- PhD, Head of Protein Design, Institute for Protein Innovation
I’m really impressed with the Lead Generation Strategies conference. The breadth of topics and quality of speakers is excellent. I’ve been involved with other CHI offerings on the biologics side but I’m so happy to know now of the excellent
programming that goes on by CHI in the small molecule space as well.
-- PhD, Laboratory Head, Encoded Library Technologies, Novartis Institutes for Biomedical Research, Chemical Biology & Therapeutics (CBT), Novartis Pharma AG
Overall the session was well organized, and the topics were diverse. I really enjoyed it. As we briefly discussed during the conference, one thing that would be beneficial to all attendees is to include as many real-world stories from drug discovery programs
as possible. I think the talks this year covered a lot of examples. It would be nice to keep this trend in the coming meetings.
-- Associate Research Fellow, Pfizer Inc.
The conference has been great and very educational. Discovery on Target brings together industry and academic leaders to share ideas. Event organizers align the program with the most exciting areas of biomedical research each year. You did a fantastic
job putting together the program!
-- Associate Member, St. Jude Children’s Research Hospital
I really enjoyed the Fibrosis sessions and WuXi NextCODE talk in the NASH session. I was really impressed with the small molecule RNA drug discovery session as so many Pharmas are doing it now. I am looking forward to this area growing.
-- PhD, General Partner, Trillium Ventures
Very informative and well prepared. Highly recommend to others.
-- Director of HTS, University of Illinois
Not only were all the talks on fragment based drug discovery enlightening to listen to but the best part was participating in the breakout discussion groups! These sessions allowed for individuals with different areas of expertise to exchange ideas and
experiences on a common problem in an informal manner. I am looking forward to the next CHI conference!
-- PhD, Post-Doctoral Researcher, Walter Chazin Laboratory, Center for Structural Biology, Vanderbilt University